Hazer Group (ASX:HZR) has completed its commercial demonstration plant and reactor test program, marking a step in the company's technological advancements. The achievement is expected to ...
Alterity Therapeutics (ASX:ATH), a biotechnology company focused on neurodegenerative diseases, announced positive results from its Phase 2 clinical trial of ATH434 for early-stage multiple system ...
Australia's red meat industry is celebrating a historic milestone this Australia Day, with exports surging to record levels in 2024. Data from the Department of Agriculture reveals that red meat ...
American Airlines Group (NASDAQ:AAL) has released its 2024 fourth-quarter and full-year financial results, reporting record fourth-quarter revenue of $13.7 billion and full-year revenue of $54.2 ...
Native Mineral Resources (ASX:NMR) has completed a $4 million shortfall placement as part of its $15.9 million non-renounceable entitlement offer. The funding milestone triggers a substantial ...
Gold Road Resources (ASX:GOR) has released its 2025 annual guidance and a three-year production outlook for the Gruyere Gold Mine, a joint venture with Gruyere Mining. As part of the venture with the ...
Castle Minerals (ASX:CDT) revealed results from its recent drilling campaign at the Kandia Gold prospect in Ghana's Upper West Region. The four-hole reverse circulation drilling program confirmed the ...
Shares of U.S. artificial intelligence (AI) companies dropped sharply in premarket trading following the launch of a low-cost Chinese AI assistant that has rattled investor confidence in the ...
Crypto.com has officially launched its operations in the United States, coinciding with Donald Trump’s inauguration as the 47th president, resulting in a 5% increase in the price of its native token, ...
Brian Armstrong, CEO of Coinbase, has called for a significant overhaul of the token listing process at the exchange due to the staggering number of new cryptocurrencies being created weekly, which he ...
Maggie Beer Holdings (ASX:MBH) has released a strategic review and trading update for the first half of FY25. The company's board has initiated a strategic review aimed at addressing high operating ...
Tissue Repair (ASX:TRP) announced the first patient randomisation in its Phase 3 clinical trial program for TR987, designed to treat chronic venous leg ulcers. The trial involves 600 participants and ...